|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
19411314 |
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.
Angiotensin-conver |
1.78 KB |
2021-06-06 |
|
5 |
|
121 |
2021-06-06
|
| PubMed |
32075365 |
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
At the |
1.25 KB |
2020-03-31 |
|
40 |
|
92 |
2021-06-04
|
| 2020PubMed@AikoHIRAKI |
32376603 |
Rapid development of an inactivated vaccine candidate for SARS-CoV-2.
The coronavirus disease 2019 |
1.08 KB |
2021-06-13 |
|
1 |
|
83 |
2021-06-13
|
| 2020PubMed@AikoHIRAKI |
32380510 |
Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
The outbreak of COVID-19 poses |
1.41 KB |
2021-06-13 |
|
1 |
|
118 |
2021-06-16
|
| PubMed |
32418532 |
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA |
5.69 KB |
2020-06-04 |
|
27 |
|
567 |
2021-06-07
|
| PubMed |
32442082 |
Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.
1. Introduction |
7.34 KB |
2020-06-04 |
|
24 |
|
306 |
2021-06-05
|
| 2020PubMed@AikoHIRAKI |
32532940 |
Comprehensive review of mask utility and challenges during the COVID-19 pandemic.
Masks are widely |
1.03 KB |
2021-06-04 |
|
1 |
|
75 |
2021-06-05
|
| PubMed |
32610873 |
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized p |
5.41 KB |
2020-09-23 |
|
23 |
|
416 |
2021-06-03
|
| 2020PubMed@AikoHIRAKI |
32735992 |
Design of an engineered ACE2 as a novel therapeutics against COVID-19.
The interaction between the |
1.71 KB |
2021-06-11 |
|
1 |
|
120 |
2021-06-11
|
| PubMed |
32744052 |
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory eff |
4.3 KB |
2020-08-18 |
|
24 |
|
446 |
2021-06-04
|
